Centene Corporation (CNC)
NYSEHealth CareHealthcare PlansSnapshot 2026-07-08
$67.06+1.42%
Close 2026-07-08 · 1-day change
Reading CNC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CNC free→NYSEHealth CareHealthcare PlansSnapshot 2026-07-08
Reading CNC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CNC free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
CNC represents a speculative growth investment. The current thesis state is intact, supported by strong recent financial performance, but management has shown volatility that adds risk.
The market seems to assume a stretched valuation compared to peers, with a low fragility tier indicating some stability. There is an expectations gap of 0.17, suggesting that while the stock may be seen as cheap relative to peers, it is still priced for some growth.
Management is making progress on increasing revenue and reducing debt, which supports a positive trajectory. However, the company remains loss-making, and recent earnings surprises have been erratic, indicating potential near-term risk.
The long-term thesis hinges on the ability of CNC to maintain or improve its earnings guidance, especially in relation to sector bellwethers like UNH, CVS, and ELV. Any negative shifts in these companies could impact CNC's performance.
Overall, CNC's outlook is shaped by its recent strong performance and ongoing management priorities, but it faces risks from sector dynamics and management volatility. Not investment advice.
The most important moves since the prior daily snapshot.
Management fell by 9.7 points (from 31.4 to 21.7).
Mixed, the news cuts both ways. The latest earnings beat strengthens the read, indicating strong recent performance. However, concerns about guidance and membership decline pose threats to revenue growth objectives, which could hinder future performance.
as of 2026-07-08
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Confirming the adjusted EPS guidance of greater than $3.40 shows strong earnings power. This is key for investor confidence.
Confirms:Q2 2026 adjusted EPS reported at or above $3.40.
Disproves:Q2 2026 adjusted EPS reported below $3.40.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Growth in revenues shows that the company can expand and manage costs well.
Confirms:Q2 2026 premium and service revenues increase by at least 5% year over year.
Disproves:Q2 2026 premium and service revenues increase less than 5% year over year.
Why it matters: A better HBR means the company is managing costs and making more money in Medicaid.
Confirms:Q2 2026 HBR reported below 90%.
Disproves:Q2 2026 HBR reported above 90%.
Why it matters: Reducing debt helps keep finances stable. It also builds trust with investors in management's money use.
Confirms:Debt reduced by an additional $500 million or more in Q2 2026.
Disproves:Debt remains unchanged or increases in Q2 2026.
Why it matters: Reducing debt helps with financial stability and growth.
Confirms:Centene reports an additional $1 billion in debt reduction by the end of Q2 2026.
Disproves:Debt levels remain unchanged or increase in Q2 2026.